Piper Sandler analyst Charles Neivert maintained a Sell rating on Albemarle (ALB – Research Report) today and set a price target of $85.00. The ...

Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Piper ...

US Foods (NYSE:USFD – Free Report) had its price objective boosted by Piper Sandler from $75.00 to $77.00 in a report issued ...

In a report released today, Patrick Wood from Morgan Stanley maintained a Hold rating on Dexcom (DXCM – Research Report), with a price target ...

On Wednesday, Piper Sandler expressed continued ... significant attention due to recent developments. Morgan Stanley (NYSE:MS) upgraded the company's stock rating from Underweight to Equalweight ...

On Friday, Piper ... market. Morgan Stanley (NYSE:MS), however, downgraded Nevro's stock from Equalweight to Underweight and reduced its price target due to challenges faced by the company ...

Piper Sandler upgraded Qorvo's (NASDAQ:QRVO) rating to Overweight from Neutral citing potential for improving fundamentals due to Starboard Value's involvement in the company. Shares of Qorvo rose ...

"Seven years ago, we began acquiring gaming studios to help train our earliest machine learning models, an invaluable step in ...

Morgan Stanley (NYSE:MS) adjusted its outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target from $230.00 to $220.00, yet continuing to endorse the stock with an Overweight rating.

The high target is $600, and the low is $465. Recent ratings by Piper Sandler, Morgan Stanley, and Cantor Fitzgerald suggest a $523 target, implying a 20.35% upside.